These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22372498)

  • 1. Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.
    Marchesi F; Grizzi F; Laghi L; Mantovani A; Allavena P
    Curr Pharm Des; 2012; 18(17):2432-8. PubMed ID: 22372498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights.
    Huang Q; Liu F; Shen J
    Future Oncol; 2019 Apr; 15(12):1385-1395. PubMed ID: 30880459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines, chemokine receptors, and cancer metastasis.
    Kakinuma T; Hwang ST
    J Leukoc Biol; 2006 Apr; 79(4):639-51. PubMed ID: 16478915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.
    Sjöberg E; Meyrath M; Chevigné A; Östman A; Augsten M; Szpakowska M
    Adv Cancer Res; 2020; 145():99-138. PubMed ID: 32089166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine network: new targeted therapy for pancreatic cancer.
    Matsuo Y; Takeyama H; Guha S
    Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
    Marchesi F; Piemonti L; Fedele G; Destro A; Roncalli M; Albarello L; Doglioni C; Anselmo A; Doni A; Bianchi P; Laghi L; Malesci A; Cervo L; Malosio M; Reni M; Zerbi A; Di Carlo V; Mantovani A; Allavena P
    Cancer Res; 2008 Nov; 68(21):9060-9. PubMed ID: 18974152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines and chemokine receptors: A new strategy for breast cancer therapy.
    Liu H; Yang Z; Lu W; Chen Z; Chen L; Han S; Wu X; Cai T; Cai Y
    Cancer Med; 2020 Jun; 9(11):3786-3799. PubMed ID: 32253815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of apoptosis: promising therapy in pancreatic cancer.
    Liu Z; Li D; Zheng X; Wang E; Wang J
    Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.
    Cimadamore A; Scarpelli M; Piva F; Massari F; Gasparrini S; Doria A; Cheng L; Lopez-Beltran A; Montironi R
    Future Oncol; 2017 May; 13(12):1105-1114. PubMed ID: 28147707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulating the chemokine-chemokine receptor network to treat cancer.
    Ruffini PA; Morandi P; Cabioglu N; Altundag K; Cristofanilli M
    Cancer; 2007 Jun; 109(12):2392-404. PubMed ID: 17503430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
    Huang L; Ma B; Ma J; Wang F
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chemokines in breast cancer pathology and its possible use as therapeutic targets.
    Palacios-Arreola MI; Nava-Castro KE; Castro JI; García-Zepeda E; Carrero JC; Morales-Montor J
    J Immunol Res; 2014; 2014():849720. PubMed ID: 25165728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
    Tanaka S
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.
    Liu H; Ma Q; Xu Q; Lei J; Li X; Wang Z; Wu E
    Curr Pharm Des; 2012; 18(17):2395-403. PubMed ID: 22372500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines and chemokine receptors: new insights into cancer-related inflammation.
    Lazennec G; Richmond A
    Trends Mol Med; 2010 Mar; 16(3):133-44. PubMed ID: 20163989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines: novel targets for breast cancer metastasis.
    Ali S; Lazennec G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of liver metastasis.
    Kawada K; Hasegawa S; Murakami T; Itatani Y; Hosogi H; Sonoshita M; Kitamura T; Fujishita T; Iwamoto M; Matsumoto T; Matsusue R; Hida K; Akiyama G; Okoshi K; Yamada M; Kawamura J; Taketo MM; Sakai Y
    Int J Clin Oncol; 2011 Oct; 16(5):464-72. PubMed ID: 21847533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.
    Jacquelot N; Duong CPM; Belz GT; Zitvogel L
    Front Immunol; 2018; 9():2480. PubMed ID: 30420855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.